Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Lymphoid 2

Conditions

Lymphoma 51Lymphoma, Follicular 36Leukemia, Lymphocytic, Chronic, B-Cell 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma, Non-Hodgkin 29Lymphoma, Large B-Cell, Diffuse 25Lymphoma, Mantle-Cell 23Leukemia 23Lymphoma, Large-Cell, Immunoblastic 20Hodgkin Disease 18Burkitt Lymphoma 18Lymphoma, B-Cell, Marginal Zone 17Leukemia, Myeloid, Acute 15Myelodysplastic Syndromes 12Multiple Myeloma 12Neoplasms, Plasma Cell 9Leukemia, Myeloid, Accelerated Phase 9Myeloproliferative Disorders 8Leukemia, Myeloid, Chronic-Phase 8Congenital Abnormalities 8Waldenstrom Macroglobulinemia 7Recurrence 7Blast Crisis 7Lymphoma, T-Cell, Cutaneous 6Primary Myelofibrosis 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Dendritic Cell Sarcoma, Interdigitating 5Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, Large-Cell, Anaplastic 4

Interventions

Doxorubicin 6Cyclophosphamide 6Vincristine 5Dexamethasone 5Zidovudine 4Methotrexate 4Leucovorin 4Cytarabine 4Bleomycin 4Filgrastim 3sargramostim 2Etoposide 2Allopurinol 2tocilizumab 1fludarabine phosphate 1fludarabine 1Vinblastine 1Valganciclovir 1Thiotepa 1Tacrolimus 1Rituximab 1Prednisone 1Mitoxantrone 1Mitoguazone 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Melphalan 1Interviews as Topic 1HIV Testing 1Genes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × sargramostim × Lymphoid × Clear all
NCT00000658 2021-11-03

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed
250 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, HIV Infections

NCT00000689 2021-11-02

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
18 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, Nervous System Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡